SCHEMBL19749990

SCHEMBL19749990

CN(C)c1ccc(-n2nc(O)cc2NC(=O)Oc2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.56
MAPT P10636 4/20 0.56
KMT2A Q03164 3/20 0.56
KDM4E B2RXH2 2/20 0.56
MEN1 O00255 1/20 0.56
THRB P10828 1/20 0.56
GFER P55789 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
BCHE P06276 1/20 0.47
ACHE P22303 1/20 0.47
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
NTRK1 P04629 1/20 0.41
MAPK13 O15264 2/20 0.41
MAPK12 P53778 2/20 0.41
MAPK11 Q15759 2/20 0.41
MAPK14 Q16539 2/20 0.41
GAA P10253 3/20 0.40
USP2 O75604 1/20 0.40
NPSR1 Q6W5P4 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18593709 0.87 MAPK14 (0.49) ALDH1A1MAPTKMT2AMEN1ATM
SCHEMBL19750004 0.86 MAPK13 (0.53) ALDH1A1MAPTKMT2AGFERNTRK1
SCHEMBL17449180 0.86 MAPK13 (0.58) ALDH1A1MAPTKMT2AKDM4EMEN1
SCHEMBL19102034 0.79 RAF1 (0.41) ALDH1A1KMT2AMEN1ATML3MBTL1
SCHEMBL13860934 0.77 NTRK1 (0.70) ALDH1A1MAPTKMT2AMEN1ATM
SCHEMBL1011730 0.75 MAPK14 (0.65) ALDH1A1KMT2AMEN1ATML3MBTL1
SCHEMBL4463042 0.74 KMT2A (0.65) ALDH1A1MAPTKMT2AKDM4EMEN1
SCHEMBL1012616 0.74 MAPK13 (0.66) MAPK13MAPK12MAPK11MAPK14GAA
SCHEMBL1015652 0.74 ALDH1A1 (0.54) ALDH1A1KMT2AATML3MBTL1NTRK1
SCHEMBL15490413 0.74 KCNJ6 (0.65) ALDH1A1MAPTKMT2AMEN1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10301288-B2 Kinase inhibitors TOPIVERT PHARMA LIMITED (GB) 2019-05-28 US disclosed
US-20180086741-A1 KINASE INHIBITORS OXULAR ACQUISITIONS LIMITED (GB) 2018-03-29 US disclosed
US-9850233-B2 Kinase inhibitors RESPIVERT LIMITED (GB) 2017-12-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180086741-A1 KINASE INHIBITORS SYK, BTK, SRC ALDH1A1 4104/4885MAPT 4154/4885KMT2A 1650/4885
US-10301288-B2 Kinase inhibitors SYK, BTK, SRC ALDH1A1 4104/4885MAPT 4154/4885KMT2A 1650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.